These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37285778)

  • 1. Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis.
    Kraler S; Wenzl FA; Vykoukal J; Fahrmann JF; Shen MY; Chen DY; Chang KC; Chang CK; von Eckardstein A; Räber L; Mach F; Nanchen D; Matter CM; Liberale L; Camici GG; Akhmedov A; Chen CH; Lüscher TF;
    Atherosclerosis; 2023 Jul; 376():43-52. PubMed ID: 37285778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein electronegativity is a novel cardiometabolic risk factor.
    Hsu JF; Chou TC; Lu J; Chen SH; Chen FY; Chen CC; Chen JL; Elayda M; Ballantyne CM; Shayani S; Chen CH
    PLoS One; 2014; 9(9):e107340. PubMed ID: 25203525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between neutrophil/lymphocyte ratio combined with low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with acute coronary syndrome].
    Yuan S; Pu T; Wang Z; Li L; Gao P; Zhang L; Ma Y; Qi Q; Fan X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Mar; 34(3):274-279. PubMed ID: 35574745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk.
    Yokoyama K; Tani S; Matsuo R; Matsumoto N
    Heart Vessels; 2019 Feb; 34(2):227-236. PubMed ID: 30140959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.
    Ikezaki H; Lim E; Cupples LA; Liu CT; Asztalos BF; Schaefer EJ
    J Am Heart Assoc; 2021 Feb; 10(5):e019140. PubMed ID: 33586462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of atherogenic index of plasma for cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention with LDL-C below 1.8mmol/L.
    Wang Y; Wang S; Sun S; Li F; Zhao W; Yang H; Wu X
    Cardiovasc Diabetol; 2023 Jun; 22(1):150. PubMed ID: 37365588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
    Hagström E; Steg PG; Szarek M; Bhatt DL; Bittner VA; Danchin N; Diaz R; Goodman SG; Harrington RA; Jukema JW; Liberopoulos E; Marx N; McGinniss J; Manvelian G; Pordy R; Scemama M; White HD; Zeiher AM; Schwartz GG;
    Circulation; 2022 Aug; 146(9):657-672. PubMed ID: 35770629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.
    Miller M; Cannon CP; Murphy SA; Qin J; Ray KK; Braunwald E;
    J Am Coll Cardiol; 2008 Feb; 51(7):724-30. PubMed ID: 18279736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content.
    Marston NA; Giugliano RP; Melloni GEM; Park JG; Morrill V; Blazing MA; Ference B; Stein E; Stroes ES; Braunwald E; Ellinor PT; Lubitz SA; Ruff CT; Sabatine MS
    JAMA Cardiol; 2022 Mar; 7(3):250-256. PubMed ID: 34773460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between low-density and non-high-density lipoprotein cholesterol with incident cardiovascular disease among low-risk Iranians during 2 decades follow-up.
    Tohidi M; Asgari S; Chary A; Azizi F; Hadaegh F
    Clin Biochem; 2022; 109-110():28-36. PubMed ID: 35970222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Alirocumab on Mortality After Acute Coronary Syndromes.
    Steg PG; Szarek M; Bhatt DL; Bittner VA; Brégeault MF; Dalby AJ; Diaz R; Edelberg JM; Goodman SG; Hanotin C; Harrington RA; Jukema JW; Lecorps G; Mahaffey KW; Moryusef A; Ostadal P; Parkhomenko A; Pordy R; Roe MT; Tricoci P; Vogel R; White HD; Zeiher AM; Schwartz GG
    Circulation; 2019 Jul; 140(2):103-112. PubMed ID: 31117810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world study of low-density lipoprotein cholesterol levels and cardiovascular outcomes in Chinese: A retrospective cohort study in post-percutaneous coronary intervention acute coronary syndrome patients.
    Wang Y; Yan BP; Nichol MB; Tomlinson B; Lee VWY
    Int J Cardiol; 2017 Dec; 249():18-24. PubMed ID: 29121725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) Interactions With Low-Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS).
    Afshar M; Pilote L; Dufresne L; Engert JC; Thanassoulis G
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27108248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome.
    Koncsos P; Fülöp P; Juhász I; Bíró K; Márk L; Simonyi G; Paragh G
    Wien Klin Wochenschr; 2016 Dec; 128(23-24):858-863. PubMed ID: 27380508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes.
    Kraler S; Wenzl FA; Georgiopoulos G; Obeid S; Liberale L; von Eckardstein A; Muller O; Mach F; Räber L; Losdat S; Schmiady MO; Stellos K; Stamatelopoulos K; Camici GG; Srdic A; Paneni F; Akhmedov A; Lüscher TF
    Eur Heart J; 2022 May; 43(19):1849-1860. PubMed ID: 35567560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.